MedPro completes issuance of final tranche of Senior Secured 14% Notes due 2016

MedPro Safety Products, Inc. (OTCBB:MPSP), a leading developer of transformational technologies that enable safer medication delivery and blood collection, announced today that it has completed the issuance of a final $5 million tranche of Senior Secured 14% Notes due 2016 in a private placement with institutional investors. The terms of the Notes are the same as the Senior Secured Notes sold in the initial $25 million tranche announced on September 1. MedPro received approximately $4.6 million in net proceeds from the transaction reported today, which was managed by Cowen and Company, LLC.

"With the closing of this transaction, we have additional financial resources to accelerate the development of our remaining product portfolio without further dilution to our shareholders," said Craig Turner, Chairman and CEO of MedPro. "With the proceeds from the previously announced Notes placement and the transaction reported today, as well as the retirement of all term debt, we now have approximately $17.5 million available to execute our plan. Our goal is to generate revenue from at least one of the four products remaining in our portfolio by the end of 2011. All four of the products provide distinct advantages to both the patient and the caregiver including a higher level of safety without modifying application procedure. The response we have received from major global medical supply companies to our products has been exceptionally strong and we are actively pursuing negotiations that would position us to begin generating returns to our shareholders," Mr. Turner concluded.

Source:

 MedPro Safety Products, Inc.

Posted in:

Tags:

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
A faster, cheaper method to detect immune autoantibodies in whole blood